Intramuscular Lorazepam Dosing for Seizure Activity in Elderly Patients

Dosing Considerations for Elderly Patients

The American Academy of Pediatrics recommends a standard IM lorazepam dose for seizure activity of 0.2 mg/kg, with a maximum of 6 mg per dose, which may be repeated every 10-15 minutes if needed 2
Elderly patients require dose reduction due to decreased drug metabolism and higher risk of respiratory depression, with a recommended initial dose of 0.05-0.1 mg/kg 1

Proper IM administration technique is crucial, with deep intramuscular injection recommended 2
Close monitoring of vital signs is necessary, particularly respiratory rate and oxygen saturation, due to the risk of respiratory depression 2, 1
Blood pressure should also be closely monitored due to the risk of hypotension 2
Respiratory support should be available if needed, as benzodiazepines can cause apnea, especially in elderly patients 1
Flumazenil should be considered as a reversal agent for life-threatening respiratory depression, although it will also reverse the anticonvulsant effects 1

Elderly patients are at risk of drug interactions due to multiple medications, which may interact with lorazepam 2
Prolonged monitoring is essential due to the extended effects of lorazepam in elderly patients 2
Dosing should be adjusted for patients with hepatic or renal impairment 2
Paradoxical reactions, such as agitation, can occasionally occur in elderly patients and should be monitored 3